Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorthe Lundsgaard

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Modern Rheumatology|August 9, 2012
Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patientsKyle A Serikawa, Søren Jacobsen, Dorthe Lundsgaard, et al.
Gastroenterology Research and Practice|June 1, 2018
Evaluating IL-21 as a Potential Therapeutic Target in Crohn's DiseaseThomas Lindebo Holm, Ditte Tornehave, Henrik Søndergaard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanomaIan D Davis, Birte K Skrumsager, Jonathan Cebon, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2008
IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinomaKlaus Stensgaard Frederiksen, Dorthe Lundsgaard, Jeremy A Freeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trialIan D Davis, Ben Brady, Richard F Kefford, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Modern Rheumatology|August 9, 2012
Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patientsKyle A Serikawa, Søren Jacobsen, Dorthe Lundsgaard, et al.
Gastroenterology Research and Practice|June 1, 2018
Evaluating IL-21 as a Potential Therapeutic Target in Crohn's DiseaseThomas Lindebo Holm, Ditte Tornehave, Henrik Søndergaard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanomaIan D Davis, Birte K Skrumsager, Jonathan Cebon, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2008
IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinomaKlaus Stensgaard Frederiksen, Dorthe Lundsgaard, Jeremy A Freeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trialIan D Davis, Ben Brady, Richard F Kefford, et al.
Pageof 2